Alpha 2.0
Login Register
» Articles » PMID: 34346057

Prescribing of Direct-acting Antiviral Therapy by General Practitioners for People with Hepatitis C in an Unrestricted Treatment Program

Overview
Journal Med J Aust
Specialty General Medicine
Date 2021 Aug 4
PMID 34346057
Citations 8
Authors
Fergus Stafford
Gregory J Dore
Shawn Clackett
Marianne Martinello
Gail V Matthews
Jason Grebely
Anne C Balcomb
Behzad Hajarizadeh
Affiliations
Soon will be listed here.
Citing Articles

Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years.

Torre P, Festa M, Sarcina T, Masarone M, Persico M Viruses. 2024; 16(11).

PMID: 39599906 PMC: 11598908. DOI: 10.3390/v16111792.

Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions.

Wallace J, Richmond J, Howell J, Hajarizadeh B, Power J, Treloar C Viruses. 2022; 14(11).

PMID: 36423153 PMC: 9693003. DOI: 10.3390/v14112542.

Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia.

Yousafzai M, Alavi M, Valerio H, Hajarizadeh B, Grebely J, Dore G Viruses. 2022; 14(7).

PMID: 35891474 PMC: 9319806. DOI: 10.3390/v14071496.

Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study.

Tasavon Gholamhoseini M, Sharafi H, Hl Borba H, Alavian S, Sabermahani A, Hajarizadeh B BMJ Open. 2022; 12(6):e058757.

PMID: 35676019 PMC: 9185662. DOI: 10.1136/bmjopen-2021-058757.

Developing a primary care-initiated hepatitis C treatment pathway in Scotland: a qualitative study.

Whiteley D, Speakman E, Elliott L, Jarvis H, Davidson K, Quinn M Br J Gen Pract. 2022; .

PMID: 35606160 PMC: 9423057. DOI: 10.3399/BJGP.2022.0044.